Found 4 results
Author Title [ Type(Desc)] Year
Filters: Author is Giralt, S  [Clear All Filters]
Conference Paper
M. Pasquini, Foley, A., Carter, S., Confer, D., Horowitz, M., Gurgol, C., Giralt, S., Schilsky, R., and McCarthy, P., “Maximizing Accrual to Transplant Trials in Multiple Myeloma (MM): Lessons from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN), Eastern Cooperative Oncology Group (ECOG) and Cancer and Leukemia Group B (CALGB) Collaboration (Poster).”, in NCI ASCO Cancer Trials Accrual Symposium, Bethesda, MD, 2010.
S. M. Devine, Owza, K., Blum, W., DeAngelo, D., Stone, R. M., Wingard, J., Champlin, R., Chen, Y., Vij, R., Slack, J., Brown, R., Soiffer, R., Larson, R., Shea, T., Hars, V., Bennett, E., Spangle, S., Giralt, S., Carter, S., Horowitz, M., Linker, C., and Alyea, E. P., “A Phase II Study of Allogeneic Transplantation for Older Patients with AML in First Complete Remission Using a Reduced Intensity Conditioning Regimen: Results from CALGB 100103/BMT CTN 0502”, in 54th Annual ASH Meeting, Atlanta, GA, 2012.
Journal Article
V. T. Ho, Cutler, C., Carter, S., Martin, P., Adams, R., Horowitz, M., Ferrara, J., Soiffer, R., and Giralt, S., “Blood and Marrow Transplant Clinical Trials Network Toxicity Committee Consensus Summary: Thrombotic Microangiopathy After Hematopoietic Stem Cell Transplantation”, Biol Blood Marrow Transplant, vol. 11, pp. 571-575, 2005.
G. A. Yanik, Horowitz, M. M., Weisdorf, D. J., Logan, B. R., Ho, V. T., Soiffer, R. J., Carter, S. L., Wu, J., ,, Difronzo, N. L., Ferrara, J. L., Giralt, S., Madtes, D. K., Drexler, R., White, E. S., and Cooke, K. R., “Randomized, Double-Blind, Placebo-Controlled Trial of Soluble Tumor Necrosis Factor Receptor: Enbrel (Etanercept) for the Treatment of Idiopathic Pneumonia Syndrome After Allogeneic Stem Cell Transplantation: BMT CTN Protocol”, Biol Blood Marrow Transplant, vol. 20, no. 6, pp. 858-864, 2014.